BOSTON (Reuters) - Long-acting insulin works better than other types of injections for people who need more than pills for their type 2 diabetes, researchers reported on Thursday. Long-acting Levemir ...
LEHI, Utah, Oct. 16, 2025 /PRNewswire/ -- Non-profit pharmaceutical company Civica will launch an affordable long-acting insulin – insulin glargine-yfgn in pre-filled pens – at the lowest list price ...
CivicaScript recently announced the availability of two new products: insulin glargine-yfgn and ustekinumab-aauz.
HHS officials are moving forward with a plan to produce 4.8 million doses of H5N1 avian flu vaccine; Novo Nordisk’s long-acting insulin had a greater risk of excessively lowering patients’ blood sugar ...
The FINANCIAL — Eli Lilly and Company and Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) on December 16 announced that the U.S. Food and Drug Administration (FDA) granted approval for Basaglar ...
On May 24, an FDA advisory committee will meet to discuss the safety profile of Awiqli (insulin icodec), Novo Nordisk’s long-lasting insulin, after a study showed the drug poses an increased risk of ...
Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration (FDA) has approved Merilog, a biosimilar to the widely used insulin product Novolog (insulin ...
Hosted on MSN
What Is NPH Insulin?
NPH insulin is an older type of synthetic insulin that helps people with diabetes control their blood sugar. It’s typically injected once or twice a day at regular times and is designed to deliver a ...
For more than a century, oral insulin has been considered a "dream" therapy for diabetes, hindered by enzymatic degradation ...
A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...
On February 14, 2025, the U.S. Food and Drug Administration (“FDA”) approved Sanofi-Aventis U.S. LLC’s (“Sanofi”) MERILOG™ (insulin-aspart-szjj), a biosimilar to Novo Nordisk A/S’s (“Novo Nordisk”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results